Executive Functions in Elite Athletes

September 30, 2022 updated by: mehmet akif akinci, Istanbul Medipol University Hospital

Comparison of the Executive Functions of Elite Team-Sport and Individual-Sport Athletes

In the study, it was aimed to compare the executive functions of elite athletes who do team sports and individual sports with each other and with individuals who do not do sports.

Study Overview

Status

Completed

Conditions

Detailed Description

In the study, it was aimed to compare the executive functions of elite athletes who do team sports and individual sports with each other and with individuals who do not do sports. 60 elite athletes participating in national and international competitions between the ages of 20-30, affiliated to the Republic of Turkey Ministry of Youth and Sports and federations, and 30 individuals who did not do sports for the control group were included in the study group. Of the elite athletes, 30 were included in the team sports group and 30 in the individual sports group. Executive functions Forward and Backward Digit Span Test, Stroop Test, Trail Making Test A and B form (TMT-A, TMT-B) and Tower of London (ToL) Test evaluated with.

Study Type

Observational

Enrollment (Actual)

90

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Istanbul
      • Beykoz, Istanbul, Turkey, 34815
        • Istanbul Medipol University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 30 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Elite athletes participating in national and international competitions in Turkish Basketball Federation, Turkish Volleyball Federation and Turkish Football Federation clubs and Gaziantep Youth Sports Center

Description

Inclusion Criteria:

  • Be between 20-30 years old
  • Have been doing sports for at least 5 years
  • Being an elite athlete
  • Being actively involved in sports

Exclusion Criteria:

  • Having any psychological or neurological disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Team Sports
30 elite athletes between the ages of 20-30 who are interested in team sports
Digit Span (Forward and Backward) Test, Stroop Test, Trail Making Test A and B forms, Tower of London Test were used to evaluate executive functions.
Other Names:
  • Digit Span Test
  • Stroop Test
  • Trail Making Test
  • London Tower Test
Individual Sports
30 elite athletes between the ages of 20-30 who are interested in individual sports
Digit Span (Forward and Backward) Test, Stroop Test, Trail Making Test A and B forms, Tower of London Test were used to evaluate executive functions.
Other Names:
  • Digit Span Test
  • Stroop Test
  • Trail Making Test
  • London Tower Test
Control Group
30 healthy individuals between the ages of 20-30 who are not interested in sports
Digit Span (Forward and Backward) Test, Stroop Test, Trail Making Test A and B forms, Tower of London Test were used to evaluate executive functions.
Other Names:
  • Digit Span Test
  • Stroop Test
  • Trail Making Test
  • London Tower Test

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
London Tower Test
Time Frame: day 1
The Tower of London test is an executive function test that is particularly sensitive to planning and problem-solving skills. The Tower of London test consists of 2 tower boards and red, blue and green beads. The participant is asked to make the same shape on the tower board of the tester opposite him on his own tower board in the fewest moves. A low total score and a high correct total score indicate good planning and problem-solving abilities. The high score of total rule mistake indicates the negativities in the ability to acquire and control planning and problem-solving behavior under certain rules. The excess of the total time out indicates the difficulty in planning and problem-solving skills at a certain time. The shortness of the onset time indicates effective planning before the problem-solving response begins. The application time and the shortness of the total time indicate the speed of problem-solving.
day 1

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Digit Span Test
Time Frame: day 1
The test consists of two parts forward and backward span. The participant is asked to repeat the numbers read in one second intervals in the forward span in the same order. It assesses attention, concentration and short-term memory. In the backward span, the numbers read at one-second intervals are requested to be repeated in reverse order from the end to the beginning. Working memory, which is a component of executive functions, is evaluated. The highest score that can be obtained for the forward span is 8 points, and 7 for the backward span, for a total of 15 points.
day 1
Stroop Test
Time Frame: day 1
The Stroop test evaluates inhibitory control, which is a component of executive functions. On the card we used as test material, the words blue, green, red, yellow are written and painted in a different color than the word. The person is first asked to read the colored words printed unrelated to the color. In the second step, the person is asked to say the color of the colored words written unrelated to the color on which they are printed. The time from the "start" command to the end, the number of errors and corrections are recorded. The time difference between the two stages constitutes the interference score. Error and correction numbers are calculated. The long duration of interference, errors and corrections indicate that the person's attention is easily distracted and cannot suppress inappropriate stimuli.
day 1
Trail Making Test
Time Frame: day 1
The Trail Making test consists of two parts, A and B. In part A, the participants are asked to combine the circles with numbers randomly scattered on the paper in the correct order and follow each other (1-2-3-4-5...). In section B, there are letters and numbers randomly placed in circles. Participants are asked to combine a letter and a number in the correct sequence (1-A-2-B-3-C-4-D...) consecutively. Time is kept for both sections. The duration is expected to be short. The A part of the TMT evaluates the processing speed based on visual scanning ability, and the B part evaluates the complex attention, planning, set changing, inhibition ability, and following the sequencing.
day 1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 1, 2022

Primary Completion (ACTUAL)

May 1, 2022

Study Completion (ACTUAL)

June 1, 2022

Study Registration Dates

First Submitted

July 13, 2022

First Submitted That Met QC Criteria

August 3, 2022

First Posted (ACTUAL)

August 4, 2022

Study Record Updates

Last Update Posted (ACTUAL)

October 4, 2022

Last Update Submitted That Met QC Criteria

September 30, 2022

Last Verified

September 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • AkifAkinci

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cognitive Change

Clinical Trials on Executive Function Assessment

Subscribe